Li, L., Freed, D. C., Liu, Y., Li, F., Barrett, D. F., Xiong, W., . . . An, Z. (2021). A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial. Nature Portfolio.
Chicago Style (17th ed.) CitationLi, Leike, et al. A Conditionally Replication-defective Cytomegalovirus Vaccine Elicits Potent and Diverse Functional Monoclonal Antibodies in a Phase I Clinical Trial. Nature Portfolio, 2021.
MLA (8th ed.) CitationLi, Leike, et al. A Conditionally Replication-defective Cytomegalovirus Vaccine Elicits Potent and Diverse Functional Monoclonal Antibodies in a Phase I Clinical Trial. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.